Comment on J&J Gains Viral Therapies in $1.75 Billion Alios Acquisition - Businessweek

J&J Gains Viral Therapies in $1.75 Billion Alios Acquisition - Businessweek

New York TimesJ&J Gains Viral Therapies in $1.75 Billion Alios AcquisitionBusinessweekJohnson & Johnson (JNJ:US), the biggest maker of consumer health products, said it will acquire Alios BioPharma Inc., a developer of viral disease therapies. J&J will pay $1.75 billion in cash for closely held Alios, according to a statement today.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News